These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28848138)

  • 21. Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity.
    Zhang Y; Shen X
    Clin Cancer Res; 2007 May; 13(10):2855-64. PubMed ID: 17504983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells.
    Wang M; Liu ZM; Li XC; Yao YT; Yin ZX
    J Chemother; 2013 Jun; 25(3):162-9. PubMed ID: 23783141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dehydrobruceine B enhances the cisplatin-induced cytotoxicity through regulation of the mitochondrial apoptotic pathway in lung cancer A549 cells.
    Huang Z; Yang G; Shen T; Wang X; Li H; Ren D
    Biomed Pharmacother; 2017 May; 89():623-631. PubMed ID: 28262615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
    Zhang D; Putti TC
    Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.
    Wang H; Zhang G; Zhang H; Zhang F; Zhou B; Ning F; Wang HS; Cai SH; Du J
    Eur J Pharmacol; 2014 Jan; 723():156-66. PubMed ID: 24333218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
    Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
    Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
    Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
    PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells.
    Owen S; Zhao H; Dart A; Wang Y; Ruge F; Gao Y; Wei C; Wu Y; Jiang WG
    Int J Oncol; 2016 Nov; 49(5):1839-1847. PubMed ID: 27600495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
    Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
    Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway.
    Zhuo W; Wang Y; Zhuo X; Zhang Y; Ao X; Chen Z
    Lung Cancer; 2008 Oct; 62(1):8-14. PubMed ID: 18372076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smad7 sensitizes A549 lung cancer cells to cisplatin-induced apoptosis through heme oxygenase-1 inhibition.
    Jeon WK; Hong HY; Seo WC; Lim KH; Lee HY; Kim WJ; Song SY; Kim BC
    Biochem Biophys Res Commun; 2012 Apr; 420(2):288-92. PubMed ID: 22421218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
    Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
    PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
    Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
    J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway.
    Tang XL; Yan L; Zhu L; Jiao DM; Chen J; Chen QY
    J Pharmacol Sci; 2017 Sep; 135(1):1-7. PubMed ID: 28939129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMGB1 Enhances Drug Resistance and Promotes In Vivo Tumor Growth of Lung Cancer Cells.
    Zheng H; Chen JN; Yu X; Jiang P; Yuan L; Shen HS; Zhao LH; Chen PF; Yang M
    DNA Cell Biol; 2016 Oct; 35(10):622-627. PubMed ID: 27383136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of eIF2α suppresses cisplatin-induced A549 cell apoptosis via p38 inhibition.
    Guo L; Chen R; Ma N; Xiao H; Chen Y; Chen F; Mei J; Ding F; Zhong H
    Cancer Biother Radiopharm; 2013 May; 28(4):268-73. PubMed ID: 23570372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-β and Hypoxia/Reoxygenation Promote Radioresistance of A549 Lung Cancer Cells through Activation of Nrf2 and EGFR.
    Lee SL; Ryu H; Son AR; Seo B; Kim J; Jung SY; Song JY; Hwang SG; Ahn J
    Oxid Med Cell Longev; 2016; 2016():6823471. PubMed ID: 26904167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
    Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
    Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.